Evidence map›Paper›PMID 26275878›Full record

ArticleUrolithiasis2016

ApaL1 urokinase and Taq1 vitamin D receptor gene polymorphisms in first-stone formers, recurrent stone formers, and controls in a Caucasian population.

Serdar Aykan, Murat Tuken, Sezgin Gunes, Yigit Akin, Murat Ozturk, Serkan Seyhan, Emrah Yuruk, Mustafa Zafer Temiz, Ali Faik Yılmaz, Daniel P Nguyen

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Urolithiasis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 6 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 6 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Relationship Between theFrontiers in genetics · 2020
    Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. A functionalFrontiers in medicine · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Serdar AykanDepartment of Urology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
Murat TukenDepartment of Urology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
Sezgin GunesDepartment of Medical Biology, Ondokuz Mayis University, Samsun, Turkey.
Yigit AkinDepartment of Urology, Erzincan University, Erzincan, Turkey.
Murat OzturkBursa Training and Research Hospital, Istanbul, Turkey.
Serkan SeyhanKanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey.
Emrah YurukDepartment of Urology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
Mustafa Zafer TemizDepartment of Urology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
Ali Faik YılmazDepartment of Urology, Ondokuz Mayis University, Samsun, Turkey.
Daniel P NguyenDepartment of Urology, Bern University, Bern, Switzerland. danielphatnguyen@hotmail.com.ORCID http://orcid.org/0000-0001-6432-4467
Bağcılar Eğitim ve Araştırma Hastanesi · TROndokuz Mayıs University · TRErzincan Binali Yıldırım University · TRİstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi · TRUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to determine differences in genotype distribution and allele frequency of urokinase and vitamin D receptor (VDR) single nucleotide polymorphisms (SNPs) between first-stone formers, recurrent stone formers, and controls in a Caucasian population. A total of 86 first-stone formers, 78 recurrent stone formers, and 167 controls were included. Urokinase and VDR SNPs were tested by gene amplification followed by ApaL1 and Taq1 endonuclease digestion, respectively. Baseline variables, genotype, and allele frequencies were compared between the three groups, using descriptive statistics. Adjusted odds ratios were calculated to estimate the risk for recurrent urolithiasis associated with genotypes. We found that differences in the distribution of ApaL1 SNP and Taq1 SNP genotypes were statistically different between recurrent stone formers and first-stone formers, and between recurrent stone formers and controls. Allele frequency analysis showed that the T allele for ApaL1 SNP and the C allele for Taq1 SNP were significantly associated with recurrent urolithiasis. For Taq1 SNP, logistic regression analysis showed that the C/C genotype was associated with a more than threefold higher risk for recurrent urolithiasis. We conclude that ApaL1 and Taq1 SNPs of the urokinase and VDR genes are associated with recurrent urolithiasis in a Caucasian population.

Indexed as

AdultDeoxyribonucleases, Type II Site-SpecificFemaleGene FrequencyGenotypeHumansMaleMiddle AgedOdds RatioPolymorphism, Restriction Fragment LengthPolymorphism, Single NucleotideReceptors, CalcitriolRecurrenceRisk FactorsUrokinase-Type Plasminogen ActivatorUrolithiasisDeoxyribonucleases, Type II Site-SpecificReceptors, CalcitriolTCGA-specific type II deoxyribonucleasesUrokinase-Type Plasminogen ActivatorVDR protein, humanSingle nucleotide polymorphismUrokinaseUrolithiasisVitamin D receptor

Identifiers

PMID26275878
OpenAlexW1464695577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.